Clik here to view.
Urgent Update: Anavex Rallies After Crucial Scientific Announcement
Anavex (AVXL) shares rallied more than 60% over the past two days, breaching the 50 cent barrier for the first time in 4 months as record volume drove gains. The most direct cause behind this healthy...
View ArticleClik here to view.
Anavex Steps Towards Stage 2 Trials… Canadian Coffee Steps Into US.
Anavex Life Science’s (AVXL) leading trial drug candidate, Anavex 2-73, in a cocktail mix with the world’s best-selling Alzheimer’s drug, donepezil, will be headed for stage 2A FDA trials in the first...
View ArticleClik here to view.
QUNI, AVXL Start Week Off With A Bang
It’s the first trading hours of the week and already, there’s serious movement on two of my tech picks (web and bio) – Quint Media Inc (QUNI) and Anavex Life Sciences (AVXL). We’ve received a number of...
View ArticleClik here to view.
AVXL Secures $10 Million In Funding
For the second time this week I’m updating Anavex Life Sciences(AVXL), and frankly, I couldn’t be happier. To those who’ve been listening to me over the course of the last few weeks as I’ve been...
View ArticleClik here to view.
Urgent Update: Anavex Closes $10m Financing; Initiates Stage 2A FDA Trials
At 7:30 Wednesday morning, Anavex (AVXL) announced that it has closed a private placement of $10 million of convertible debentures with several institutional and accredited investors, including U.S....
View ArticleClik here to view.
Portfolio Recap: Stocks Strong Amidst Political Turmoil
Will nothing stop this bull market? Apparently not… Even as Russia’s rampaging President signs a bill to annex the Crimean Peninsula; and as the EU imposes new sanctions against Russia for doing so,...
View ArticleClik here to view.
Urgent Portfolio Update: “ANAVEX PLUS is a compelling commercial opportunity”
Big news today from our biopharmaceutical company, Anavex Life Sciences (AVXL): The company announced today that a report in the current issue of peer-reviewed International Pharmaceutical Industry...
View ArticleClik here to view.
Portfolio Recap: Correction Ahead?
The Dow closed flat for the week at 16,323, after briefly touching 16,450 on Wednesday, March 26th. Not too shabby considering many are predicting continued political turmoil in the Baltic region, and...
View ArticleClik here to view.
Momentum Trade Alert: Rich Pharmaceuticals, Inc. (RCHA)
This is an urgent buy alert on the pharma firm Rich Pharmaceuticals, Inc (RCHA). Rich Pharmaceuticals, Inc., is Beverly Hills California-based development stage company focused on the development of...
View ArticleClik here to view.
Portfolio Update: Anavex Fetches $7 Price Target From Leading Investment Firm
The Maxim Group, a NY-based investment banking, securities and investment management firm, initiated coverage of Anavex Life Sciences last week, setting their initial price target at $7/share. Just to...
View Article
